Your browser doesn't support javascript.
loading
A cross-sectional observational study of health-related quality of life in adults with multiple myeloma.
LeBlanc, Matthew R; Bryant, Ashley Leak; LeBlanc, Thomas W; Yang, Qing; Sellars, Emily; Chase, Cristiana Costa; Smith, Sophia K.
Afiliación
  • LeBlanc MR; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel, Hill 101 Manning Drive, , Chapel Hill, NC, 27514, USA. matthew_leblanc@unc.edu.
  • Bryant AL; University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, USA.
  • LeBlanc TW; Duke University School of Medicine, Durham, USA.
  • Yang Q; Duke Cancer Institute, Durham, USA.
  • Sellars E; Duke University School of Nursing, Durham, USA.
  • Chase CC; Duke University School of Medicine, Durham, USA.
  • Smith SK; Duke University School of Medicine, Durham, USA.
Support Care Cancer ; 30(6): 5239-5248, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35262791
ABSTRACT

BACKGROUND:

The purpose of this manuscript is to describe health-related quality of life (HRQoL) outcomes in a United States (US)-based sample of multiple myeloma (MM) patients and identify characteristics associated with poor HRQoL. PATIENTS AND

METHODS:

MM patients identified through the Tumor Registry of a Southeastern US medical center were mailed surveys assessing patient characteristics and HRQoL outcomes. HRQoL outcomes were measured using PROMIS short form instruments which included measures of global health (global physical health and global mental health), physical function, and ability to participate in social roles and activities (social function). HRQoL domain scores were summarized, and best subset linear regression was used to identify predictors of HRQoL.

RESULTS:

A total of 690 patients completed and returned surveys for a response rate of 64.7%. Respondents reported global physical health (44.9), global mental health (47.5), and physical function (44.1) significantly worse than the general population mean of 50 (p < .0001). Social function (49.5) did not differ significantly (p = .09). Worse socioeconomic status, higher comorbidities, not being in remission, and past receipt of radiation therapy were significantly associated with worse HRQoL. Treatment status and time since diagnosis were not associated with HRQoL outcomes.

CONCLUSIONS:

Patients with MM have significantly worse HRQoL than the general population. These findings warrant increased attention from clinicians and researchers. More research is needed to better describe the relationship between treatment patterns and HRQoL in patients with MM, and to identify effective interventions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Mieloma Múltiple Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Mieloma Múltiple Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos